Apple Inc. said its hypertension detection system for its smart watch will arrive next week after receiving clearance Thursday from the US Food and Drug Administration.
The feature, which was announced at Apple’s most recent product launch event in early September, will be available in 150 countries and regions, including the US, Hong Kong and the European Union. The company previously said it was waiting for approval from the FDA and other regulators.